[Studies on the antituberculous activities of rifampicin (REP) and the period of exposure in vitro (author's transl)].
D004352:Drug Resistance, Microbial; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D012293:Rifampin / Q000494:pharmacology*; D013997:Time Factors
D012293:Rifampin